Abstract
AbstractThis paper outlines the impact of the COVID-19 pandemic on cancer services in the UK including screening, symptomatic diagnosis, treatment pathways and projections on clinical outcomes as a result of these care disruptions. A restoration of cancer services to pre-pandemic levels is not likely to mitigate this adverse impact, particularly with an ageing population and increased cancer burden. New cancer cases are projected to rise to over 500,000 per year by 2035, with over 4 million people living with and beyond cancer. This paper calls for a strategic transformation to prioritise effort on the basis of available datasets and evidence—in particular, to prioritise cancers where an earlier diagnosis is feasible and clinically useful with a focus on mortality benefit by preventing emergency presentations by harnessing data and analytics. This could be delivered by a focus on underperforming groups/areas to try and reduce inequity, linking near real-time datasets with clinical decision support systems at the primary and secondary care levels, promoting the use of novel technologies to improve patient uptake of services, screening and diagnosis, and finally, upskilling and cross-skilling healthcare workers to expand supply of diagnostic and screening services.
Funder
DH | NIHR | Research Trainees Coordinating Centre
Royal Marsden Partners
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Mountain of almost 50,000 people still missing a cancer diagnosis in the UK as NHS already struggling to cope with existing demand, November 26,2021, Macmillan press release, https://medium.com/macmillan-press-releases-and-statements/mountain-of-almost-50-000-people-still-missing-a-cancer-diagnosis-in-the-uk-as-nhs-already-f533f178cef3 and The Forgotten ‘C’? The impact of Covid-19 on cancer care – Macmillan cancer support, October 2020, https://www.macmillan.org.uk/assets/forgotten-c-impact-of-covid-19-on-cancer-care.pdf.
2. Armitage RC, Morling JR. The impact of COVID-19 on national screening programmes in England. Public Health. 2021;198:174–6. https://doi.org/10.1016/j.puhe.2021.07.022.
3. Round T, Ashworth M, L’Esperance V, Møller H. Cancer detection via primary care urgent referral and association with practice characteristics: a retrospective cross-sectional study in England from 2009/2010 to 2018/2019. Br J Gen Pract. 2021;71:e826–35.
4. Round T, Gildea C, Ashworth M, Møller H. Association between use of urgent suspected cancer referral and mortality and stage at diagnosis: a 5-year national cohort study. Br J Gen Pract. 2020;70:e389–98.
5. Nicholson BD, Ordóñez-Mena JM, Lay-Flurrie S, et al. Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care. Br J Cancer. 2021. https://doi.org/10.1038/s41416-021-01666-6.